A Study of TAK-505 in Adults With Solid Tumors
NCT07436728
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
151
Enrollment
INDUSTRY
Sponsor class
Conditions
Malignant Solid Tumors
Interventions
DRUG:
TAK-505
Sponsor
Takeda